| Authors: |
Murdock HM; Division of Hematologic Neoplasia, Department of Medical Oncology, and., Kim HT; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Denlinger N; Division of Hematology, The Ohio State University James Cancer Hospital, Columbus, OH., Vachhani P; Division of Hematology and Oncology, University of Alabama at Birmingham School of Medicine, Birmingham, AL., Hambley B; Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH., Manning BS; Department of Medicine, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA., Gier S; Department of Medicine, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA., Cho C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Tsai HK; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA., McCurdy S; Department of Medicine, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA., Ho VT; Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Koreth J; Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Soiffer RJ; Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ritz J; Division of Hematologic Neoplasia, Department of Medical Oncology, and., Carroll MP; Department of Medicine, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA., Vasu S; Division of Hematology, The Ohio State University James Cancer Hospital, Columbus, OH., Perales MA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Wang ES; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Gondek LP; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD., Devine S; National Marrow Donor Program, Minneapolis, MN; and., Alyea EP; Duke Cancer Institute, Duke University Medical Center, Durham, NC., Lindsley RC; Division of Hematologic Neoplasia, Department of Medical Oncology, and., Gibson CJ; Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. |
